background: Fresh embryo transfer results in higher live birth rates, while thawed embryo transfer appears to result in healthier babies. This study aims to investigate the association between the transfer of fresh or thawed embryos at the cleavage or blastocyst stage and the perinatal outcomes.
Introduction
In the past three decades, assisted reproductive technology (ART) treatment has evolved numerous variations in clinical practice to achieve a pregnancy. In a typical ART cycle, fresh cleavage stage embryo(s) are transferred (Stepoe and Edwards, 1978; Mettler et al., 1984) . In recent years, with the merits of cryopreservation and blastocyst culture, fresh blastocyst(s), thawed cleavage stage embryo(s) and thawed blastocyst(s) have also been transferred (Jones et al., 1998; Centers for Disease Control and Prevention, 2008; Nyboe Andersen et al., 2008; Wang et al., 2009) .
The outcome of embryo transfers in terms of clinical pregnancy and live delivery are associated with various patient demographic and treatment factors. Studies show that a number of patient demographic characteristics, such as patient age, parity, cause and duration of subfertility are independently associated with pregnancy following ART treatment (Bai et al., 2002; ESHRE Capri Workshop Group, 2004; Baird et al., 2005) . The literature also demonstrates that the transfer of more than one embryo results in a higher pregnancy rate compared with the transfer of only one embryo (Giannini et al., 2004; Pandian et al., 2005) . Recently published studies also found that, after adjustment for patient demographics and number of embryos transferred, the pregnancy and live delivery rates are higher for the transfer of blastocyst embryos compared with cleavage stage embryos (Papanikolaou et al., 2008) and also higher for the transfer of fresh compared with frozen/thawed embryos (Human Fertilization and Embryology Authority, 2007 ; Centers for Disease Control and Prevention, 2008; Wang et al., 2009) .
However, in relation to baby outcomes, recent evidence suggests that better perinatal outcomes follow the transfer of frozen/thawed embryos rather than fresh embryos (Wang et al., 2005; Shih et al., 2008) . Babies conceived by the transfer of thawed embryos may have significantly lower rates of preterm birth and perinatal mortality than those following the transfer of fresh embryos (Shih et al., 2008) . Live born babies are also less likely to be low-birthweight following the transfer of thawed compared with fresh embryos (Wang et al., 2005) .
It has been advocated that the outcome of ART treatment needs to focus on 'Birth Emphasizing a Successful Singleton at Term' (Healy, 2004) . Our study developed a newly proposed indicator the 'healthy baby' as the optimum outcome of ART treatment. A 'healthy baby' was defined as a single baby born live at term, weighing ≥2500 g, surviving for at least 28 days post birth and not having congenital anomalies. Our study aims to investigate the association between the rates of live delivery and 'healthy baby' and the transfer of fresh or thawed embryos at the cleavage or blastocyst stage, and to suggest a practice model combining fresh and thaw cycles which could result in better perinatal outcomes.
Materials and Methods

Data
Data and definitions used in this study are from the Australian and New Zealand Assisted Reproduction Database (ANZARD), located at the Perinatal and Reproductive Epidemiology Research Unit of University of New South Wales (UNSW). Data for ANZARD are collected annually, in a de-identified format, from all fertility centres within Australia and New Zealand. The ANZARD includes information on both the in vitro fertilization (IVF) treatment cycle [oocyte pick-up, IVF and intracytoplasmic sperm injection (ICSI) fertilization procedure, use of thawed embryos, blastocyst culture, embryo transfer and donation of gametes or embryos] and the pregnancy and birth outcomes (birth status, gestational age, birthweight and congenital anomalies).
A sub-data set on the embryo transfer cycles undertaken in Australian clinics between 1 January 2002 and 31 December 2006 and resulting pregnancy and birth outcomes were extracted from ANZARD. Mixed freshthawed embryo transfer cycles and mixed cleavage/blastocyst embryo transfer cycles were excluded. A total of 150 376 embryo transfer cycles, where women 18 years and older used their own oocytes (autologous cycles), were included in the final analysis.
Study factors
Transferred embryos were categorized as fresh cleavage embryo, fresh blastocyst, thawed cleavage embryo, blastocyst from thawed cleavage embryo and thawed blastocyst. The type of fertilization was classified either as IVF or ICSI. The numbers of transferred embryos were grouped as single embryo (SET), double embryo (DET) and three or more embryos.
The woman's age was calculated in completed years of age at the time of treatment. The cause of infertility was classified as male factor only, female factor only (tubal disease, endometriosis or other female factor problems were diagnosed), combined male -female factor (both male and female factor problems were diagnosed), unexplained (neither male nor female factor problems was diagnosed) or not stated. Previous pregnancy of ≥20 weeks gestation was grouped as yes, no or not stated.
Main outcome measures
Gestational age was defined as the number of completed weeks of gestation and calculated by the formula '(pregnancy end date2embryo transfer date) + 16 days' for cleavage embryo transfer and '(pregnancy end date2embryo transfer date) + 19 days' for blastocyst transfer. A clinical pregnancy was defined by one of the following criteria: evidence by ultrasound of intrauterine sac(s) and/or fetal heart(s); examination of products of conception revealing chorionic villi; an ectopic pregnancy that had been diagnosed laparoscopically or by ultrasound. A live delivery was defined as a birth event in which one or more babies were born live at ≥20 weeks gestation, or of ≥400 g birthweight.
A newly proposed indicator, the 'healthy baby', was utilized to define the best perinatal outcome. A 'healthy baby' was defined as single a baby born live at term (≥37 weeks gestational age), weighing ≥2500 g, surviving for at least 28 days post birth and not having known congenital anomalies (major or minor).
Statistical analysis
Patient demographics (woman's age, cause of infertility and previous pregnancy of ≥20 weeks gestation) and treatment factors (type of fertilization and number of transferred embryos) were compared in the various embryo transfer groups, namely fresh or thawed embryos at cleavage or blastocyst stage. Chi-square test was used to test the difference in pregnancy outcomes between IVF and ICSI procedure, and between SET and DET. Pregnancy rate per transfer cycle, live delivery rate per transfer cycle and the rate of 'healthy baby' per transfer cycle were calculated and compared for the various embryo transfer groups. The associations between the transfer of fresh or thawed embryos at the cleavage or blastocyst stage and the rates of live delivery and 'healthy baby' were investigated in univariate and multivariate logistic regression. Odds ratios (OR), adjusted odds ratios (AOR) (adjusted for woman's age, cause of infertility, previous pregnancy of ≥20 weeks gestation, type of fertilization and number of embryo transferred) and 95% confidence intervals (CI) were calculated. Data were analysed using SPSS software, version 17.0 (SPSS, Inc., Chicago, IL, USA).
Ethics
Ethics approval for this study was granted by the Human Research Ethics Committee of the UNSW, Australia.
Results
Nearly half (46.1%) of the 150 376 autologous cycles involved the transfer of fresh cleavage embryo(s), with 33.0% thawed cleavage embryo(s), 12.9% fresh blastocyst(s), 6.2% thawed blastocyst(s) and 1.8% with transfer of blastocyst(s) from thawed cleavage embryos. Approximately 20% of fresh embryo transfer cycles were in women aged 40 years or older (21.2% for fresh cleavage embryo cycles and 18.9% for fresh blastocyst cycles), compared with ,15% of thawed embryo transfer cycles (15.6% for thawed cleavage embryo cycles, 10.9% for thawed blastocyst cycles and 12.0% for cycles with transfer of blastocyst(s) cultured from thawed cleavage embryo(s)). Cycles with transfer of thawed cleavage embryo(s) had the highest proportion of female factor only infertility (37.8%). Three quarters of fresh embryo cycles were in women who never had a pregnancy of 20 weeks or more gestation (75.3% for fresh cleavage embryo cycles and 74.3% for fresh blastocyst cycles) ( Table I) .
More than half the blastocyst transfer cycles had an SET (55.7% of fresh blastocyst cycles, 66.4% of thawed blastocyst cycles and 60.8% of cycles with transfer of blastocyst from thawed cleavage embryo(s)). SET occurred in 35.5% of fresh cleavage embryo cycles and 43.8% of thawed cleavage embryo cycles (Table I) .
Cycles with transfer of blastocyst(s) from thawed cleavage embryo(s) had the lowest proportion of ICSI procedures, followed by cycles with transfer of thawed blastocyst(s) ( Table I) .
The pregnancy rate per transfer cycle ranged from 20.1% for transfer of thawed cleavage embryo(s) to 35.9% for transfer of fresh blastocyst(s). Cycles with transfer of fresh blastocyst(s) resulted in the highest live delivery rate (27.9%), followed by blastocyst(s) from thawed cleavage embryo(s) (22.0%), fresh cleavage embryo(s) (21.7%), thawed blastocyst(s) (16.3%) and thawed cleavage embryo(s) (15.2%). More than one in five of the fresh blastocyst cycles resulted in a 'healthy baby', compared with 16.2% in cycles with transfer of blastocyst(s) from thawed cleavage embryo(s), 14.8% in fresh cleavage embryo cycles, 13.2% in thawed blastocyst cycles and 11.7% in thawed cleavage embryo cycles (Table II) .
In cycles with transfer of fresh blastocyst(s), the live delivery rate was significantly higher for IVF procedures than for ICSI procedures (29.0 versus 27.0%, P , 0.01). However, there was no significant difference in the 'healthy baby' rate between IVF and ICSI procedures with fresh or thawed embryos at cleavage or blastocyst stage (Table III) .
The live delivery rate was significantly higher for DET than for SET in cycles with transfer of fresh cleavage embryo(s) (24.0 versus 18.6%, P , 0.01), thawed cleavage embryo(s) (17.4 versus 12.4%, P , 0.01), blastocyst(s) from thawed cleavage embryo(s) (24.9 versus 20.1%, P , 0.01) and thawed blastocyst (s) (Table IV) . Of all fresh embryo transfer cycles, transfer of fresh cleavage embryo(s) had significantly lower odds of live delivery than fresh blastocyst(s) (the group with the highest rates of live delivery and 'healthy baby') (AOR 0.67, 95% CI 0.64 -0.69). Compared with transfer of fresh blastocyst(s), the likelihood of a live delivery was significantly lower for blastocyst(s) from thawed cleavage embryo(s) (AOR 0.71, 95% CI 0.64 -0.79), for thawed blastocyst(s) (AOR 0.50, 95% CI 0.47 -0.54) and for thawed cleavage embryo(s) (AOR 0.46, 95% CI 0.44 -0.48) ( Table V) .
Compared with transfer of fresh blastocyst(s) the chance of achieving a 'healthy baby' was significantly lower for blastocyst(s) from thawed cleavage embryo(s) (AOR 0.73, 95% CI 0.65-0.82), fresh cleavage embryo(s) (AOR 0.67, 95% CI 0.64 -0.69), thawed blastocyst(s) (AOR 0.57, 95% CI 0.53 -0.62) and thawed cleavage embryo(s) (AOR 0.53, 95% CI 0.51 -0.56) ( Table V) .
Thawed cleavage embryo cycles and thawed blastocyst cycles were also less likely to produce a 'healthy baby' (AOR 0.80, 95% CI 0.77 -0.84; and AOR 0.86, 95% CI 0.81 -0.92, respectively) compared with fresh cleavage embryo cycles. There was no significant difference in the odds of 'healthy baby' between transfer of fresh cleavage embryo(s) and blastocyst(s) from thawed cleavage embryo(s) (AOR 1.10, 95% CI 0.98 -1.22).
Of thawed embryo transfer cycles, both thawed cleavage embryo cycles (AOR 0.71, 95% CI 0.63-0.79) and thawed blastocyst cycles (AOR 0.79, 95% CI 0.70-0.89) had significantly lower odds of 'healthy baby' compared with cycles with transfer of blastocyst(s) from thawed cleavage embryo(s) ( Table V) . Thawed cleavage embryo cycles were also less likely to produce a 'healthy baby' compared with thawed blastocyst cycles (AOR 0.89, 95% CI 0.84 -0.97).
Discussion
This population-based study found that the transfer of fresh blastocyst(s) had a significantly better perinatal outcomes measured as a 'healthy baby' [single baby born live at term (≥37 weeks gestation), weighing ≥2500 g, surviving for at least 28 days post birth and not having congenital anomalies]. Of thaw cycles, transfer of blastocyst(s) from thawed cleavage embryo(s) had higher rates of live delivery and 'healthy baby' than transfer of thawed cleavage embryo(s) and thawed blastocyst(s). This study suggests that transfer of fresh blastocyst(s) in fresh cycles and blastocyst(s) from thawed cleavage embryo(s) in thaw cycles would result in more 'healthy babies'.
The strength of this retrospective cohort study is the large study population and the comprehensive coverage of all embryo transfer cycles performed in Australia from 2002 to 2006. This produces a significant study power and allows us to generalize the results that would not be possible from a clinic-based study. One limitation of this study is the potential variability in reporting of perinatal outcomes. Birthweight, gestation and plurality at birth are reliably defined from the various data sources, including hospital records, self-reporting by patients and their obstetricians. However, the information on pregnancy and birth outcomes was not stated in 1.7% of clinical pregnancies in the study. In addition, the information on congenital anomalies from ANZARD was likely to be incomplete. A comparative study of a regional birth defect register with practitioner reporting in Australia found congenital anomalies were under reported in the assisted conception database . This study's definition of a 'healthy baby' is restricted to singletons. This eliminates the potential confounders and selection bias of multiple pregnancies with their poorer perinatal outcomes (Ombelet et al., 2005) , increased risk to mothers (Campbell and Templeton, 2004) and greater economic and social burden on the parents and on the health care system . The definition of 'healthy baby' was based on term gestation, normal birthweight and without known congenital anomalies including both minor and major congenital anomalies. Preterm birth and low-birthweight are related to the short-and long-term health conditions of a baby (Goldstein, 1981) . Most major congenital anomalies require surgery or other medical intervention and are related to early death (Walden et al., 2007) . Even minor congenital anomalies are also related to future development of a baby (Sutcliffe et al., 1995) .
Consistent with other studies, we found that the live delivery rate per transfer cycle was higher with fresh blastocyst embryo transfer than with fresh cleavage-stage embryo transfer (Butterworth, 2001; Papanikolaou et al., 2008) . An explanation of the difference is the natural selection that occurs with the two or three additional days in culture which allows a reduction in the number of chromosomally abnormal embryos. Hence, it is proposed that the best embryos survive through the blastocyst culture process (Butterworth, 2001) .
However, this difference in live delivery rates between fresh blastocysts and cleavage embryos is reduced when the denominator used is the initiated cycle rather than the transfer cycle because there is a reduced embryo utilization rate between blastocysts and cleavage embryos. A recent study found that the rate of embryo transfer cancellation was significantly higher in blastocyst transfer cycles than in cleavage embryo transfer cycles (Papanikolaou et al., 2008) . As our study is retrospective, it is not possible to determine the decisions for the stage of transfer. The standard practice in Australian and New Zealand IVF clinics at the time was planned cleavage embryo (Wang et al., 2009) . A randomized controlled trial suggested that among women under 36 years of age who are undergoing a first or a second ART treatment cycle, transfer of a single blastocyst significantly increases the probability of live birth when compared with transfer of a single cleavage embryo (Papanikolaou et al., 2006) . Our study found that without adjusting for woman's age and number of previous ART treatment cycles, transfer of a single fresh blastocyst resulted in the highest rates of live delivery (30.7%) and 'healthy baby' (25.8%). The continued increase in single fresh blastocyst transfers results in better outcomes following ART treatment.
Another important change in clinical practice is the use of vitrification to cryopreserve embryos. Vitrification was first introduced into Australian ART clinics in 2006 (Costigan et al., 2007) , the last year of our 5 year study. Data are not available from ANZARD on vitrification of embryos during the treatment period 2002-2008 and are not included in the study. Population-based monitoring of the safety and quality of vitrification is important as some studies suggest that vitrification may increase the embryo survival rate during both the freezing and thawing processes compared with slow freezing (Takahashi et al., 2005; Rezazadeh Valojerdi et al., 2009) . Takahashi et al. (2005) suggests that transfer of thawed blastocysts following vitrification would achieve the same pregnancy and implantation rates similar to transfer of fresh blastocysts. There is a limited published information on baby outcomes following vitrification. More population-based evidence of the baby outcomes following vitrification compared with slow freezing is needed to guide the future clinical practice.
Our study found that cycles with transfer of blastocyst(s) from thawed cleavage embryo(s) resulted in significantly better outcomes than thawed cleavage embryo transfer cycles and thawed blastocyst transfer cycles. Interestingly, the rates of live delivery and 'healthy baby' following transfer of blastocyst(s) from thawed cleavage embryo(s) were statistically similar to transfer of fresh cleavage(s) despite the physical insults of freezing and thawing. Apart from natural selection in post-thaw blastocyst culture process as discussed above (Butterworth, 2001) , the freezing/thawing process is also considered as another selection process for the improved outcomes following transfer of blastocyst(s) from thawed cleavage embryo(s) (Anja et al., 2009) . It is also suggested that embryos which are able to survive the freezing and thawing process are likely to be healthier and so result in better outcomes (Anja et al., 2009) . In addition to the above, the natural uterine environment for a thaw cycle, which is similar to spontaneous pregnancy, may also play a role in improved perinatal outcomes (Shih et al., 2008) . There have also been suggestions of a negative effect of fresh cycles where the pre-replacement treatment including controlled FSH ovarian stimulation, anesthesia and surgery for oocyte collection might affect early pregnancy with later effects on baby outcomes (Shih et al., 2008) .
This large cycle-based study would suggest that the optimum practice model would be that in the initial fresh cycle where there are adequate numbers of good quality cleavage embryos, a proportion are frozen at the cleavage stage and a small cohort of three or four is cultured onto the blastocyst stage and a single blastocyst is transferred. Subsequently, the frozen embryos would be thawed and cultured onto blastocyst stage for transfer (Fig. 1) . This model should result in higher rate of live delivery and more 'healthy babies'. The suggested practice model would be primarily applicable to good prognosis patients who have a number of oocytes fertilized. For those patients, such as younger patients undergoing first ART treatment, there is evidence that the cancellation rate is not significantly different between the cleavage and blastocyst stages (Blake et al., 2007) .
The suggested model does not reflect the current practice. In Australia and New Zealand, the vast majority of clinics either transfer and freeze at the cleavage stage or transfer and freeze at the blastocyst stage in fresh cycles. In this study, of the 48 255 fresh cycles in which embryos were transferred and frozen, only 641 cycles (1.3%) had blastocyst(s) transferred and cleavage embryo(s) frozen. Reasons for such a small proportion of cycles with blastocyst(s) transferred and cleavage embryo(s) frozen need further investigation but may suggest that this group is inherently at a higher potential to conceive because of large numbers of cleavage embryos. The efficacy of this model, which is derived from this large, comprehensive epidemiological study, warrants prospective evaluation at a clinical level.
